Please provide your email address to receive an email when new articles are posted on . The weight loss and cardiometabolic benefits of tirzepatide were greater among early responders to treatment.
Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback